Zomedica Corp. (NYSE: ZOM) just announced that it has signed a definitive agreement to acquire substantially all of the assets of Revo Squared LLC.
Shares of Zomedica Corp. opened just over 10% higher than its previous close.
“We are excited to join the team at Zomedica; this deal will bring our MicroView product offering into the forefront of veterinary medicine. For the first time clinicians will be able to have hematology and cytology slides automatically smeared and stained inside a microscope, eliminating human error in slide preparation. Implementing MicroView in veterinary hospitals enhances diagnostics and reduces the wait time,” Bill Campell, Chief Executive Officer of Revo Squared said.
Revo’s MicroView digital cytology platform will provide veterinarians with best-in-class image quality while providing the first in-clinic automated slide preparation system and improves practice workflow efficiency by automating the process to assure a consistent smear and stain in order to produce a readable slide.
“We’re excited to reach a definitive agreement with Revo Squared and intend to close the transaction within 30 days.” said Zomedica Vice President of Business Development and Strategic Planning, Greg Blair, “This furthers Zomedica’s commitment to bring innovative technologies and tools to market that improve pet outcomes and pet parent satisfaction while also improving veterinary practice workflow efficiency and economics.